The European medical cannabis market is a tough nut to crack for Canadian cannabis firms who face a more stringent regulatory regime than at home. Aphria’s shares rose by more than 10% after it became the latest Canadian Licensed Producer (LP) to secure European Union Good Manufacturing Practice (EU-GMP) clearance for two of its domestic … Continue reading Only A ‘Dozen’ Domestic Canadian LP Facilities Have Secured EU-GMP Compliance